Holocene Advisors, LP Certara, Inc. Transaction History

Holocene Advisors, LP

$31.7 Billion
Q1 2025

A detailed history of Holocene Advisors, LP transactions in Certara, Inc. stock. As of the latest transaction made, Holocene Advisors, LP holds 73,063 shares of CERT stock, worth $859,951. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,063

Holding current value

$859,951

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$9.9 - $14.25 $723,323 - $1.04 Million	73,063 New	73,063 $723,000
Q3 2022 Nov 14, 2022	SELL	$12.84 - $24.13 $462,445 - $869,066	-36,016 Reduced 69.13%	16,085 $214,000
Q2 2022 Aug 15, 2022	BUY	$16.75 - $22.54 $417,426 - $561,719	24,921 Added 91.69%	52,101 $1.12 Million
Q1 2022 May 16, 2022	BUY	$17.89 - $28.73 $486,250 - $780,881	27,180 New	27,180 $584,000
Q4 2021 Feb 14, 2022	SELL	$26.1 - $45.21 $1.56 Million - $2.71 Million	-59,842 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.46 - $38.41 $754,957 - $1.19 Million	-30,865 Reduced 34.03%	59,842 $1.98 Million
Q2 2021 Aug 16, 2021	SELL	$24.79 - $33.31 $5.4 Million - $7.26 Million	-217,898 Reduced 70.61%	90,707 $2.57 Million
Q1 2021 May 17, 2021	BUY	$25.58 - $39.0 $7.89 Million - $12 Million	308,605 New	308,605 $8.43 Million

Others Institutions Holding CERT

# of Institutions

258

Shares Held

121M

Call Options Held

54.1K

Put Options Held

19K

Black Rock Inc. New York, NY

13.4M
Shares

$158 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

12.4M
Shares

$147 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

9.29M
Shares

$109 Million
0.52% of portfolio
Dimensional Fund Advisors LP Austin, TX

7.92M
Shares

$93.3 Million
0.02% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

7.5M
Shares

$88.3 Million
1.36% of portfolio

View Full List

About Certara, Inc.

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.88B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

More about CERT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Account